Summary:
The purpose of this study is to evaluate the efficacy of vibegron compared to placebo in patients within symptoms of overactive bladder (OAB), specifically the frequency of mictruitions (toilet voids) and frequency of urge urinary incontinence episodes. Also, to evaluate the safety and tolerability of treatment with vibegron.
Qualified Participants Must:
• Be at least 18 years of age
•
Have at least 8 mictruitions (toilet voids) per day
•
Have not had bladder surgery or pelvic surgery within the last 6 months
•
Must not have had electrostimulation or bladder training therapy within the last 28 days
•
Must not have had more than 3 UTI's within the last year
Qualified Participants May Receive:
- Study related procedures and lab work
- Compensation for time and travel expenses
- Oversight by a board certified physician